Table 2.

Correlation between TAK1/TAB1 expression and clinicopathological grading of non-small cell lung carcinoma

Group	Total cases	TAK1		P	TAB1		P
		Positive cases	Negative cases		Positive cases	Negative cases
Gender				0.21			0.88
Male	54	32	22		28	26
Female	20	15	5		10	10
Age (year)				0.37			0.24
<65	38	26	12		17	21
≥65	36	21	15		21	15
Degree of differentiation				0.61			0.79
Low	18	13	5		10	8
Moderate	29	20	9		16	13
High	17	14	3		11	6
Clinical stage				0.0002			<0.0001
I, II	39	17	22		11	28
III, IV	35	30	5		27	8
Lymph node metastasis				0.005			0.001
Yes	43	33	10		29	14
No	31	14	17		9	22
Smoking				0.32			0.97
Yes	41	24	17		21	20
No	33	23	10		17	16
Tumor size (cm)				0.58			0.24
<3	38	23	15		17	21
≥3	36	24	12		21	15

TAK1: transforming growth factor beta-activated kinase 1; TAB1: TAK1-binding protein 1.